Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Umeclidinium bromide (substance) |
Is a |
False |
Umeclidinium (substance) |
Inferred relationship |
Some |
|
Product containing umeclidinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
1 |
Product containing umeclidinium in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Umeclidinium (substance) |
Inferred relationship |
Some |
|
Product containing fluticasone and umeclidinium and vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
3 |
Product containing fluticasone and umeclidinium and vilanterol in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Umeclidinium (substance) |
Inferred relationship |
Some |
|
Fluticasone- and umeclidinium- and vilanterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
3 |
Product containing umeclidinium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
1 |
Product containing only umeclidinium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
1 |
Product containing only fluticasone and umeclidinium and vilanterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
3 |
Fluticasone and umeclidinium and vilanterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
3 |
Product containing only umeclidinium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
1 |
Umeclidinium bromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
|
Umeclidinium (as umeclidinium bromide) 55 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Umeclidinium (substance) |
Inferred relationship |
Some |
1 |